Guideline & Testing Update for Treatment of Invasive Fungal Infections in Hospitalized Patients- The incidence of invasive fungal infections continues to increase, resulting in significant morbidity and mortality, despite the introduction of expanded treatment options. Clinicians require up-to-date knowledge of advances in testing approaches and novel antifungal agents to guide clinician-decision making and ensure that at-risk patients receive prompt, appropriate therapy.
Identify patients at risk of invasive fungal infections in critical care and other hospital settings.
Compare and contrast the mechanisms of action, pharmacokinetics, efficacy, and safety of available and emerging antifungal agents.
Apply diagnostic and susceptibility testing for invasive fungal infections to ensure prompt, appropriate antifungal therapy.
Implement strategies to enhance empiric and definitive antifungal therapy for candidemia.
1.25 Free AMA Pra CAT 1 CME for Physicians
Expires 11/18/15
Supported by an educational grant from Astellas Scientific & Medical Affairs, Inc.
